Literature DB >> 22190699

Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.

Jamie A Le1, Heather M Wilson, Aurora Shehu, Jifang Mao, Y Sangeeta Devi, Julia Halperin, Tetley Aguilar, Anita Seibold, Evelyn Maizels, Geula Gibori.   

Abstract

Prolactin (PRL), a pleiotropic hormone essential for maintenance of corpus luteum (CL) function and pregnancy, transduces its signal through two types of receptors, a short form (PRLR-S) and a long form (PRLR-L). Both types of receptors are expressed in the CL, yet their individual roles are not well defined. We have shown previously that female transgenic mice expressing only PRLR-S display total infertility characterized by defective follicular development and early degeneration of CL, suggesting that expression of PRLR-L is a prerequisite for normal follicular development and maintenance of CL. To determine whether PRLR-L alone is the sole receptor required to maintain normal CL formation, differentiation, and progesterone secretion, we generated two transgenic mice which express only PRLR-L, either ubiquitously (Tg-RL) or in a CL-specific manner (CL-RL). To generate CL-specific expression, we used the HSD17B7 promoter. We found both transgenic mice models cycled normally, displayed no apparent defect in follicular development, and had normal ovulation rates. The STAT5 signaling pathway, considered essential for luteinization and progesterone production, was activated by PRL in both transgenic mice models. However, soon after mating, Tg-RL and CL-RL mice showed early regression of CL, lack of progesterone production, and implantation failure that rendered them totally infertile. Embryo transfer studies demonstrated no embryo abnormalities, and supplementation with progesterone rescued implantation failure in these mice. Close observation revealed lack of luteinization and reduced expression of proteins involved in progesterone biosynthesis despite normal levels of LHCGR (LH-R), ESR1 (ER-alpha), CEBPB (C/EBP-beta) and CDKN1B (p27), proteins essential for luteinization. However, we found VEGFA, a key regulator of angiogenesis and vascularization, to be dramatically reduced in both Tg-RL and CL-RL mice. We also found collagen IV, a marker for the basal lamina of endothelial cells, aberrantly expressed and a discordant organization of endothelial cells in CL. Although luteinization did not occur in vivo, granulosa cells isolated from these mice luteinized in culture. Taken together, these results suggest that a vascularization defect in the CL may be responsible for lack of luteinization, progesterone production, and infertility in mice expressing only PRLR-L. This investigation therefore demonstrates that in contrast to earlier presumptions that PRLR-L alone is able to support normal CL formation and function, both isoforms of the PRL receptor are required in the CL for normal female fertility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22190699      PMCID: PMC3316271          DOI: 10.1095/biolreprod.111.095927

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  62 in total

Review 1.  Regulation and manipulation of angiogenesis in the primate corpus luteum.

Authors:  H M Fraser; S F Lunn
Journal:  Reproduction       Date:  2001-03       Impact factor: 3.906

2.  Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model.

Authors:  E Bonanno; M Iurlaro; J A Madri; R F Nicosia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

3.  Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.

Authors:  D L Russell; J S Richards
Journal:  Mol Endocrinol       Date:  1999-12

Review 4.  From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models.

Authors:  V Goffin; N Binart; P Clément-Lacroix; B Bouchard; C Bole-Feysot; M Edery; B K Lucas; P Touraine; A Pezet; R Maaskant; C Pichard; C Helloco; N Baran; H Favre; S Bernichtein; A Allamando; C Ormandy; P A Kelly
Journal:  Genet Anal       Date:  1999-11

Review 5.  Prolactin regulation of estrogen receptor expression.

Authors:  Jonna Frasor; Geula Gibori
Journal:  Trends Endocrinol Metab       Date:  2003-04       Impact factor: 12.015

6.  Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration.

Authors:  N Binart; C Helloco; C J Ormandy; J Barra; P Clément-Lacroix; N Baran; P A Kelly
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

7.  PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.

Authors:  J Frasor; U Barkai; L Zhong; A T Fazleabas; G Gibori
Journal:  Mol Endocrinol       Date:  2001-11

8.  Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription.

Authors:  J Frasor; K Park; M Byers; C Telleria; T Kitamura; L Y Yu-Lee; J Djiane; O K Park-Sarge; G Gibori
Journal:  Mol Endocrinol       Date:  2001-12

9.  Opposite effect of prolactin and prostaglandin F(2 alpha) on the expression of luteal genes as revealed by rat cDNA expression array.

Authors:  C Stocco; E Callegari; G Gibori
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

10.  Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation.

Authors:  Elise Saunier; Fariel Dif; Paul A Kelly; Marc Edery
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

View more
  8 in total

1.  The long and short of the prolactin receptor: the corpus luteum needs them both!

Authors:  Carlos Stocco
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

2.  Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Authors:  Hadley J Hartwell; Keiko Y Petrosky; James G Fox; Nelson D Horseman; Arlin B Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

Review 3.  Mice with gene alterations in the GH and IGF family.

Authors:  Yanrong Qian; Darlene E Berryman; Reetobrata Basu; Edward O List; Shigeru Okada; Jonathan A Young; Elizabeth A Jensen; Stephen R C Bell; Prateek Kulkarni; Silvana Duran-Ortiz; Patricia Mora-Criollo; Samuel C Mathes; Alison L Brittain; Mat Buchman; Emily Davis; Kevin R Funk; Jolie Bogart; Diego Ibarra; Isaac Mendez-Gibson; Julie Slyby; Joseph Terry; John J Kopchick
Journal:  Pituitary       Date:  2021-11-19       Impact factor: 4.107

4.  The absence of ER-β results in altered gene expression in ovarian granulosa cells isolated from in vivo preovulatory follicles.

Authors:  April K Binder; Karina F Rodriguez; Katherine J Hamilton; Patricia S Stockton; Casey E Reed; Kenneth S Korach
Journal:  Endocrinology       Date:  2013-04-11       Impact factor: 4.736

5.  Beclin-1 deficiency in the murine ovary results in the reduction of progesterone production to promote preterm labor.

Authors:  Thomas R Gawriluk; CheMyong Ko; Xiaoman Hong; Lane K Christenson; Edmund B Rucker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

6.  The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.

Authors:  Huizhen Nie; Pei-Qi Huang; Shu-Heng Jiang; Qin Yang; Li-Peng Hu; Xiao-Mei Yang; Jun Li; Ya-Hui Wang; Qing Li; Yi-Fan Zhang; Lei Zhu; Yan-Li Zhang; Yanqiu Yu; Gary Guishan Xiao; Yong-Wei Sun; Jianguang Ji; Zhi-Gang Zhang
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

7.  Prolactin and dexamethasone regulate second messenger-stimulated cl(-) secretion in mammary epithelia.

Authors:  Utchariya Anantamongkol; Mei Ao; Jayashree Sarathy Nee Venkatasubramanian; Y Sangeeta Devi; Nateetip Krishnamra; Mrinalini C Rao
Journal:  J Signal Transduct       Date:  2012-07-25

8.  Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.

Authors:  Antonela Sofía Asad; Alejandro Javier Nicola Candia; Nazareno Gonzalez; Camila Florencia Zuccato; Araceli Abt; Santiago Jordi Orrillo; Yael Lastra; Emilio De Simone; Florence Boutillon; Vincent Goffin; Adriana Seilicovich; Daniel Alberto Pisera; María Jimena Ferraris; Marianela Candolfi
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.